Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists hunt for clues in COVID Patients' blood and secretions

NCT ID NCT04956445

First seen Jun 03, 2026 · Last updated Jun 23, 2026 · Updated 3 times

Summary

This study collects blood and nasal secretions from up to 2,000 people with COVID-19 to learn why some get very sick while others recover easily. Researchers will also track long-term symptoms like fatigue and brain fog. No treatments are tested—the goal is to gather data to guide future countermeasures.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tulane University Medical Center

    RECRUITING

    New Orleans, Louisiana, 70112, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University Medical Center New Orleans

    RECRUITING

    New Orleans, Louisiana, 70112, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could clarify why some people get severe COVID-19 and others don't, and help develop better treatments or vaccines.

What could go wrong

This is an observational study, not a treatment trial. It may not lead to any direct medical advances, and results may take years to apply.

Conditions

The condition(s) this trial relates to.

COVID-19 Post-Acute COVID-19 Syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.